Carbohydrate-induced modulation of cell membrane. VIII. Agglutination with mammalian lectin galectin-1 increases osmofragility and membrane fluidity of trypsinized erythrocytes  by Gupta, Rajesh K. et al.
FEBS Letters 580 (2006) 1691–1695Carbohydrate-induced modulation of cell membrane.
VIII. Agglutination with mammalian lectin galectin-1 increases
osmofragility and membrane ﬂuidity of trypsinized erythrocytes
Rajesh K. Guptaa, Abhay H. Pandea,1, Krishana C. Gullaa, Hans-J. Gabiusb, Krishnan Hajelaa,*
a School of Life Sciences, Devi Ahilya Vishwavidyalaya, Khandwa Road, Indore 452017, India
b Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University, Veterina¨rstr. 13, 80539 Mu¨nchen, Germany
Received 18 January 2006; revised 3 February 2006; accepted 7 February 2006
Available online 17 February 2006
Edited by Jesus AvilaAbstract Interaction of lectins with cell surface determinants
may alter membrane properties. Using trypsinized rabbit eryth-
rocytes as model we tested the capacity of an endogenous lectin
in this respect. Galectin-1 is a member of an adhesion/growth-
regulatory family known to interact for example with ganglioside
GM1 and also the hydrophobic tail of oncogenic H-Ras. Assays
on membrane ﬂuidity and osmofragility detect galectin-1’s
capacity to increase the parameters. Moreover, it increases sus-
ceptibility of erythrocytes to radical damage. These observations
indicate the potential of this endogenous lectin to aﬀect mem-
brane properties beyond the immediate interaction with cell sur-
face epitopes.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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A hallmark of lectin activity is the agglutination of cells via
cross-linking of surface glycans. This lectin-dependent associa-
tion of glycans may aﬀect membrane features such as ﬂuidity.
Also, there is the possibility that a lectin might interact with
hydrophobic membrane patches adding to its impact on mem-
brane characteristics. In this report, we focus on a member of
a family of endogenous lectins in this respect. The galectins are
known to interact with distinct surface glycans to trigger adhe-
sion, growth regulation or migration/tissue invasion [1–3]. Of
note, their secretion follows a non-classical pathway [4–7], and
the chimera-type galectin-3, a weak agglutinin, is even capable
to traverse liposomalmembranes in either direction [8].With fo-
cus on proto-type galectin-1, a homodimeric lectin, it is known
that it preferentially binds to ganglioside GM1 on neuroblas-
toma cells to exert growth control [9–11] and that it harbors a site
to interact with hydrophobic tails of oncogenic H-Ras [12].Abbreviations: PBS, 0.01 M phosphate buﬀer (pH 7.4) with 0.15 M
NaCl; EPR, electron paramagnetic resonance
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doi:10.1016/j.febslet.2006.02.006These observations indicate capacity for glycolipid binding
and the possibility to associate with hydrocarbon chains. Using
hemolysis of red blood cells as model system we herein test the
hypothesis that galectin-1 can perturb the lipid bilayer. Indeed,
agglutination of trypsinized red blood cells with galectin-1 re-
sulted in increase in membrane ﬂuidity, enhancing the cells’
osmofragility and their susceptibility to free radical damage.2. Materials and methods
Spin label 16-doxyl stearic acid (16-DS) and spin trap N-t-butyl-a-
phenyl nitrone (PBN), trypsin and chymotrypsin were purchased from
Sigma (St. Louis, MO). Pyrogallol, trisodium citrate and other chem-
icals used were from Loba Chemicals, India. The glass capillaries used
were from Top Syringe Manufacturing Co. (Bombay, India).
Galectin-1 from sheep liver and goat liver was isolated as described
previously [13] and identity of the puriﬁed protein with galectin-1 was
conﬁrmed by amino acid sequencing of a partial trypsin digest [14]. In
order to maintain galectin-1 activity in non-reducing environment,
batches of carboxyamidomethylated galectin-1 (cam-galectin-1) were
regularly prepared by reacting the galectin with 25 mM iodoacetamide
at 4 C for 8 h in Tris/HCl buﬀer (pH 7.5) containing 150 mM NaCl
and 5 mM b-mercaptoethanol in the presence of lactose [15]. The
galectin-containing solution was extensively dialysed against buﬀer
without mercaptoethanol to remove excess iodoacetamide. Rabbit
red blood cells were trypsinized as described previously [16]. The osmo-
fragility of galectin-1-agglutinated erythrocytes and protection of their
lysis by addition of non-electrolytes were determined as described else-
where [17]. Brieﬂy, aliquots of 200 ll of a 2% RBC suspension in
0.01 M phosphate buﬀer (pH 7.4) with 0.15 M NaCl (PBS) were mixed
with 100 ll of either galectin-1-containing solution in 10 mM Tris/HCl
(pH 7.5) containing 150 mm NaCl and 5 mM b-mercaptoethanol or
same buﬀer without lectin (control). The suspension was incubated
for 1 h at 30 C to obtain agglutination. After this period 1.5 ml of
PBS or sugars (30 mM) in PBS were added and cells were incubated
under these conditions for 1–6 h with gentle mixing (by hand). The
tubes were then centrifuged at 3000 · g for 5 min, supernatant col-
lected and absorbance measured at 550 nm. Results are reported as
percentage of lysis, the extent of lysis of identical volume of erythro-
cyte suspension in distilled water being set to 100%. Agglutinated cells
were exposed to superoxide radical, generated from a pyrogallol auto-
oxidation system by adding 10 ll of pyrogallol solution (0.02 M freshly
made in H2O) and incubated for a period of 20 min at 30 C [16]. The
released oxyhemoglobin concentration in supernatants was measured
by method of Winterbourne [18]. Spin labeling of galectin-treated
erythrocytes by 16-DS, spin trapping of superoxide radical by PBN
and electron paramagnetic resonance (EPR) spectroscopy were done
as recently described [16]. The galectin-1-agglutinated (lysed) cells were
washed three times with PBS to remove excess of hemoglobin. The
cells were resuspended in 190 ll of PBS, followed by addition of
10 ll of 16-DS (2.6 · 105 M ﬁnal conc.) and incubated for a period
of 30 min at 30 C. Thereafter, 50 ll of 10 mM Tris/HCl (pH 7.5)blished by Elsevier B.V. All rights reserved.
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1692 R.K. Gupta et al. / FEBS Letters 580 (2006) 1691–1695buﬀer containing 16 mM NiCl2 and 100 mM NaCl were added, the
suspension kept at 30 C for 10 min. Cells were then again washed
three times with PBS and resuspended in 100 ll of PBS. About 50 ll
were then ﬁlled into glass capillaries, and EPR spectra were recorded
on a Varian E 104 EPR spectrometer. Instrument settings were as fol-
lows: scan range 100 G; ﬁeld set 3237 G; temperature 27 C; time con-
stant 1 s; scan time 4 s; modulation amplitude 2 G; modulation
frequency 100 kHz; microwave power 5 mW; microwave frequency
9.1 kHz and receiver gain 2.5 · 104. The rotational correlation time
Tc was calculated as described previously [16]. The b-galactoside-bind-
ing immunoglobulin G fraction was puriﬁed from immunoglobulin G
of human serum by aﬃnity chromatography on lactosylated Sepharose
4B, obtained by divinyl sulfone activation, any reactivity for a-galacto-
sides was removed by a second step of aﬃnity chromatography and
binding assays ascertained the activity, as described previously [19–22].0
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Fig. 2. Eﬀect of incubation time on sheep hepatic galectin-1-induced
hemolysis of trypsinized rabbit erythrocytes in isotonic PBS. The
agglutination of erythrocytes was carried out at a concentration of
2.2 lM of sheep hepatic galectin-1, and agglutinated cells were
incubated for designated time period at 30 C. galectin-1 (–d–), cam-
galectin-1 (–s–). Bars represent standard deviation from four obser-
vations.
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The osmotic fragility of rabbit erythrocytes in the presence
and absence of galectin-1 (at reducing conditions, kept in pres-
ence of b-mercaptoethanol), and cam-galectin-1 (in absence of
b-mercaptoethanol) was studied by measuring their hemolysis
in isotonic solutions. In detail, erythrocytes were agglutinated
with increasing concentrations of galectin-1 (0.5 to 2.5 lM) in
isotonic PBS for 6 h at 30 C and hemolysis measured by mon-
itoring the optical density of the supernatant at 550 nm for
presence of hemoglobin. The results are presented in Fig. 1.
With increase in concentration of both galectin-1 preparations,
the percentage of hemolysis was enhanced. Under identical
conditions control erythrocytes incubated without galectin
exhibited no hemolysis. Quantitative aspects of the prepara-
tions diﬀered. About 62.6% reduction in hemolysis was ob-
served at 2.5 lM of galectin-1 used when free thiol groups
were blocked by carboxyamidomethylation, indicating that
the free thiol groups play an important role in this hemolytic
activity. Similar results were obtained when goat hepatic galec-
tin-1 and bovine heart galectin-1 were used (data not shown).
The hemolysis of galectin-1-agglutinated erythrocytes in iso-
tonic PBS at increasing period of incubation and temperature
was also studied. The percentage of hemolysis correlated with0
20
40
60
80
100
0 0.5 1 1.5 2 2.5
SHG-1 Concentration, µM
H
em
ol
ys
is
, %
Fig. 1. Eﬀect of change of concentration of sheep hepatic galectin-1 on
hemolysis of trypsinized rabbit erythrocytes in isotonic PBS. The
incubation was carried out for 6 h at 30 C. galectin-1 (–d–), cam-
galectin-1 (–s–). Bars represent standard deviation from four obser-
vations.
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Fig. 3. Eﬀect of incubation temperature on sheep hepatic galectin-1-
induced hemolysis of trypsinized human erythrocytes in isotonic PBS.
The agglutination of erythrocytes was carried out at a concentration of
2.2 lM of sheep hepatic galectin-1, and agglutinated cells were
incubated for 6 h at diﬀerent temperature. Open bars (h) represent
galectin-1-agglutinated erythrocytes and ﬁlled bars ( ) represent cam-
galectin-1-agglutinated erythrocytes. Bars represent standard deviation
from four observations.prolonging period of incubation (Fig. 2) and raising the tem-
perature of incubation (Fig. 3). To examine carbohydrate
dependence, the eﬀect of inhibitory sugars on hemolysis of
erythrocytes by galectin-1 was then studied. Galectin-1 (re-
duced) and cam-galectin-1 were pre-incubated with b-lactose
(20 mM ﬁnal concentration), then incubated with erythrocytes,
and hemolysis was assayed after 6 h of incubation at 30 C.
The reduced galectin-1 induces 72% hemolysis. Presence of lac-
tose led to an about 22.2% inhibition of hemolysis. When cam-
galectin-1 was used, hemolysis was 26.9% which decreased to
16.4% in the presence of 20 mM lactose, thereby exhibiting
R.K. Gupta et al. / FEBS Letters 580 (2006) 1691–1695 169338.8% inhibition. Incubation with lactose could thus not abol-
ish galectin-1-induced hemolysis.
Presuming that the increased hemolysis of lectin-agglutinated
cells is due to the formation of membrane leaks for small ions,
attempts were made to prevent the colloid osmotic lysis by addi-
tion of non-electrolytes (osmoprotectants) to the extracellular
medium. These non-electrolytes are capable to counterbalance
the osmotic pressure exerted by intracellular macromolecules.
These non-electrolyte solutes will only act protectively for an
unlimitedperiod, if theyhave virtually no access to the leakpath-
way. If conversely they permeate slowly, they will gradually lose
activity. The ability of non-electrolyte solutes to protect galec-
tin-1-induced hemolysis was assessed after various time periods
of incubation. The results are presented in Fig. 4. The erythro-
cytes were agglutinated with 2.2 lM galectin-1 (reduced) and
then incubated with either isotonic PBS or PBS containing
30 mM of glucose, sucrose, raﬃnose or PEG-3000. The
osmomolaritywasmaintained at 280 mosmol/l [17]. The incuba-
tion was carried out at 30 C for 6 h and hemolysis measured.
Cells agglutinated with reduced galectin-1 in PBS exhibited
16.5%, 76.5% and 96.2% hemolysis at 2, 6 and 10 h of incuba-
tion. Addition of glucose caused no protection from hemolysis.
Addition of 30 mM sucrose or 30 mM raﬃnose decreased the
galectin-induced hemolysis. Presence of 30 mMPEG-3000 com-
pletely protected the hemolysis for up to 6 h of incubation. Only
8% hemolysis was observed at 10 h incubation. When cam-
galectin-1 was used, 26% hemolysis was observed after 6 h of
incubation. Addition of glucose had no protective eﬀect. Addi-
tion of 30 mM sucrose, raﬃnose and PEG-3000 decreased
hemolysis to 10%, 5% and 0.5%, respectively. Glucose had no
eﬀect on hemolysis as it could be able to penetrate the leak.How-
ever, addition of sucrose, a disaccharide, raﬃnose, a trisaccha-
ride, and PEG-3000 were able to provide protection from
hemolysis, intimating limiting size of the pore.
As further parameter to detect membrane changes, we exam-
ined the status of ﬂuidity of erythrocyte membrane subsequentPBS Glc Suc Raf PEG
Colloidal Additive
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Fig. 4. Eﬀect of period of incubation on protection of colloid-osmotic
hemolysis of trypsinized rabbit erythrocytes agglutinated with galectin-
1 (2.2 lM) in PBS by addition legend to ﬁgures of non-electrolyte. The
incubation was carried out for designated time period (h) 2 h; ( ) 6 h;
( ) 10 h at 30 C. PBS, phosphate-buﬀered saline; Glc, glucose 30 mM;
Suc, sucrose 30 mM; Raf, raﬃnose 30 mM; PEG, poly (ethylene
glycol)-3000 30 mM. Bars represent standard deviation from four
observations.to galectin-1 binding using the stearic acid spin label 16-DS as
probe. The EPR spectra were analysed by computing the rota-
tional correlation time Tc, a measure of the degree of immobi-
lization of the spin label, hence of local viscosity. The
reciprocal of Tc (1/Tc) denotes ﬂuidity. The membrane ﬂuidity
(1/Tc) of RBC incubated with galectin-1 (reduced) increased
from 0.18 · 1010 s1 at 1.1 lM galectin-1 concentration to
0.73 · 1010 s1 at 4.5 lM galectin-1 (reduced) concentration
(P < 0.001) (Fig. 5). Control erythrocytes had a 1/Tc value of
0.1 · 1010 s1. A slight increase in membrane ﬂuidity from
0.12 · 1010 to 0.24 · 1010 s1 was also observed when erythro-
cytes were agglutinated with cam-galectin-1 at concentrations
of 1.1 and 4.5 lM. The increase in ﬂuidity, however, did not
reach the same high level of signiﬁcance (P < 0.01).
To assess whether the enhanced membrane ﬂuidity upon
agglutination with galectin-1 increases the susceptibility of
cells to free radical damage, galectin-1-agglutinated cells were
exposed to superoxide radicals generated by pyrogallol auto-
oxidation. It was found, that when erythrocytes were aggluti-
nated with 1.1 lM of reduced galectin-1 for 1 h and then ex-
posed to superoxide radicals, they released 13.13 lM of
oxyhemoglobin (Fig. 6). When a galectin-1 concentration of
2.2 lMwas used, 47.23 lM of oxyhemoglobin were detectable,
erythrocytes exposed to superoxide anion in the absence of
galectin-1 gave only 1.7 lM of oxyhemoglobin. No lysis was
obtained with cells exposed to galectin-1 for only 1 h and con-
trol cells which were not exposed to both galectin-1 and super-
oxide anions. Obviously, the presence of galectin-1 increases
the susceptibility of erythrocytes for superoxide damage. The
damage was triggered in erythrocytes in the ﬁrst hour of agglu-
tination with galectin-1, and prolonged incubation (4 h) with
galectin-1 did not enhance extent of damage. These results
were obtained using a very low concentration of free radical
generated by auto-oxidation of pyrogallol at a ﬁnal concentra-
tion of 0.65 mM. Superoxide anion cannot traverse the lipid
bilayer due to its charge.0
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Fig. 5. Membrane ﬂuidity 1/Tc measurements of RBC treated with
reduced and camsheep hepatic galectin-1. Membrane ﬂuidity (1/Tc
value) of erythrocytes only (a; control), erythrocytes incubated either
with galectin-1 or cam-galectin-1 at ﬁnal concentrations of 1.1 lM (b),
2.2 lM (c), 3.3 lM (d) or 4.4 lM (e), respectively, (h) open bars
represent galectin-1-agglutinated erythrocytes and ( ) ﬁlled bars
represent cam-galectin-1-agglutinated erythrocytes. Bars represent
standard deviation from four observations.
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Fig. 6. Oxyhemoglobin concentration in the supernatant of erythro-
cytes only (a; control), erythrocytes incubated with galectin-1 (b;
1.1 lM ﬁnal concentration), erythrocytes exposed to superoxide
radicals (c), erythrocytes exposed to superoxide radicals in the presence
of 2.2 lM (ﬁnal concentration) of sheep hepatic galectin-1 (d) after 1 h
of incubation, erythrocytes exposed to superoxide radicals in the
presence of 2.2 lM (ﬁnal concentration) of sheep hepatic galectin-1
after 4 h of incubation (e), erythrocytes exposed to superoxide radicals
in the presence of 1.1 lM (ﬁnal concentration) of galectin-1 after 1 h of
incubation (f). Bars represent standard deviation of mean values from
four observations.
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we tested anti-Rh antibodies which failed to induce any hemo-
lysis in spite of the fact that it causes a strong haemagglutina-
tion reaction with human Rh +ve erythrocytes [17]. Incubation
with a b-galactoside antibody also did not produce any hemo-
lysis. This antibody, however, did not agglutinate trypsinized
human erythrocytes (data not shown).4. Discussion
Our study has focused on the question as to whether lectin
binding has an impact on membrane properties. Commonly,
plant lectins are used for such a purpose in model studies
[23]. To add physiological relevance, we selected an endoge-
nous adhesion/growth-regulatory lectin with a jelly-roll folding
pattern [24]. Whereas recently reported interaction of the chi-
mera-type galectin-3 with membrane lipids might be attribut-
able to the two non-carbohydrate recognition domains [8],
we herein show that the proto-type galectin-1 lacking these do-
mains exerts strong impacts on erythrocyte membrane integ-
rity and ﬂuidity. As with its non-classical export [7],
carbohydrate-dependent binding plays a role in this process.
When entering the hydrophobic environment, consequences
of the way galectin-1 changes its quaternary structure can be-
come relevant. In the aprotic solvent dimethyl sulfoxide oligo-
merization to a tetramer which exhibited a cylindrical shape
was detected [25]. Diﬀerential scanning calorimetry also pro-
vided evidence for oligomerization [26], a tentative argument
for a potential of this galectin to form a pore. Alternatively,
the selective clustering of distinct glycoconjugates can lead to
this end. Of note, cross-linking activity is essential for a variety
of galectin functions, as is the inherent selectivity for distinct
binding partners, for example the ﬁbronectin receptor [27,28].This local clustering can result in substantial reorganisation of
membrane components inducing destabilization or perturba-
tion of membrane functionality. The interface between the lipid
bilayer andmembrane-spanning proteins is tightly sealed in nor-
mal bio-membranes, where a rugged surface of a protein might
have to contact alkyl chains [29]. A lateral phase displacement
of membrane proteins into new environments may produce a
mismatch between a lipid and peptide chains establishing an
aqueous pore [30]. Also, aggregates of clustered membrane pro-
teins might form aqueous channels penetrating the lipid bilayer
even though the walls of these channels would be constituted by
rather hydrophobic protein domains. An increase in tempera-
ture increases the rate of diﬀusion of electrolytes through the
pore, and enhanced membrane ﬂuidity favours clustering of
membrane receptors establishing a pore. That aqueous pores
have formed on erythrocyte surface after agglutination by galec-
tin-1 is indicated by protection of lysis by high-molecular-weight
non-electrolytes (osmoprotectants) added in extracellular med-
ium. The lag in the induction of leak formation after galectin-1
binding may probably represent induction of a threshold level
of membrane damage. Induction of such a threshold appears
to be a general mechanism in the permeabilization of cells by
pore-forming agents [31,32]. Having described such an activity
for galectin-1, it is now tempting to test members of other sub-
families of galectins in this respect, e.g., tandem-repeat-type
galectins. In addition to their emerging role as growth modula-
tors, galectins-4 and -9 are either crucial components of lipid
rafts or harbor activity as transmembrane urate transporter
[33–35]. These roles render these proteins attractive targets for
further studies.
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